COMMONWEALTH EQUITY SERVICES, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2021$3,717,000
+1597.3%
55,782
+3111.4%
0.01%
+800.0%
Q3 2019$219,000
+4.8%
1,7370.0%0.00%0.0%
Q2 2019$209,000
-7.9%
1,737
-33.3%
0.00%0.0%
Q1 2019$227,000
-12.7%
2,6050.0%0.00%0.0%
Q4 2018$260,000
-12.8%
2,6050.0%0.00%0.0%
Q3 2018$298,000
+19.7%
2,605
-6.1%
0.00%0.0%
Q2 2018$249,0002,7750.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders